U.S. Food and Drug Administration Approves Kaleo's EVZIO™ for the

U.S. Food and Drug Administration Approves Kaleo's EVZIO™ for the
Abrupt reversal of opioid effects in persons who were physically dependent on opioids has precipitated signs and symptoms of opioid withdrawal including: body aches, fever, sweating, runny nose, sneezing, piloerection, yawning, weakness, shivering or …
Read more on PR Newswire (press release)